Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
US Department of Justice
Citi
Boehringer Ingelheim
Healthtrust
Julphar
Dow
Fish and Richardson

Generated: January 21, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: Ranbaxy Labs Ltd

« Back to Dashboard

Ranbaxy Labs Ltd Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Ranbaxy Labs Ltd lamivudine; tenofovir disoproxil fumarate 202529 300MG; 300MG TABLET; ORAL
Ranbaxy Labs Ltd pravastatin sodium 076445 80MG TABLET;ORAL
Ranbaxy Labs Ltd pravastatin sodium 076445 10MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
Medtronic
Citi
UBS
McKinsey
Fuji
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.